At the Children's Hospital of New York, our pediatric nephrologists from Columbia and Weill Cornell Medicine provide compassionate care for newborns to young adults with acute and chronic kidney disease. They remain on the forefront of discoveries that advance prevention, diagnosis, and treatment of these conditions, including renal replacement therapy and transplant for end-stage renal disease.
Pediatric Nephrology
Stay up to date with the latest in Pediatric care
The NYP Advances newsletter delivers groundbreaking research and advancements straight to your inbox.
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, Chair of Otolaryngology–Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
